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Patent Ductus Arteriosus in Preterm InfantsSixty-seven percent of very low birth weight infants
(weighing between 1000 and 1500 g at birth) will sponta-
neously close their ducts by 7 days after birth (94% will
close before hospital discharge).1 On the other hand,
spontaneous ductus closure occurs in only 30% to 35% of
infants weighing ＜1000 g at birth during the neonatal
period.2 Premature infant with hemodynamically significant
patent ductus arteriosus (PDA) was linked to broncho-
pulmonary dysplasia, prolonged ventilation, pulmonary
hemorrhage, necrotizing enterocolitis, renal impairment,
intraventicular hemorrhage, and death.3 Echocardiographic
and Doppler criteria for the confirmation of a significant
PDA include the following: (1) demonstration of left to right
shunt; (2) left atrial/aortic root ratio ＞1.3; (3) ductal size
greater than 1.5 mm; and (4) disturbed diastolic flow in the
main pulmonary artery with a diastolic backflow in the
aorta immediately below the ductus arteriosus and
a forward flow above the ductal insertion.4
The initial medical management for neonates with
hemodynamically significant PDA includes fluid restriction,
diuretics, correction of anemia, and acid/base imbal-
ances.5 When first-line medical management fails, phar-
macological therapy with cyclooxygenase inhibitors
(indomethacin or ibuprofen) is generally the standard
treatment of choice.6 Intravenous ibuprofen and indo-
methacin have a similar efficacy in PDA closure, but
premature infants treated with ibuprofen have fewer side
effects on the renal, mesenteric, and cerebral blood flows.7
It has been reported that oral ibuprofen suspension may be
an effective and safe alternative for PDA.8
Surgical ligation for premature infant with significant PDA
produces definitive ductus arteriosus closure; however, it is
associated with its own set of morbidities: thoracotomy,
penumothorax, chylothorax, scoliosis, and infection.9 It has
also been reported that premature infant with PDA ligation
increases the risk for bronchopulmonary dysplasia, retinop-
athy of prematurity and neurosensory impairment.10
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